Teladoc Health, Inc. (TDOC) Q2 2024 Earnings Call Transcript
Teladoc Health, Inc. (NYSE:TDOC ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Michael Minchak - Head of Investor Relations Conference Call Participants Lisa Gill - J.P. Morgan Stephanie Davis - Barclays Jess Tassan - Piper Sandler Jailendra Singh - Truist Securities Richard Close - Cannacord Genuity Elizabeth Anderson - Evercore ISI Sarah James - Cantor Fitzgerald Sean Dodge - RBC Capital Markets Charles Rhyee - TD Cowen Michael Cherny - Leerink Partners Daniel Grosslight - Citi Operator Hello all, and welcome to Teladoc Health Second Quarter 2024 Earnings Call.
Teladoc (TDOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Teladoc (TDOC) Reports Q2 Loss, Misses Revenue Estimates
Teladoc (TDOC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.40 per share a year ago.
Teladoc posts another quarterly loss, and online mental-health unit sees revenue slip
Shares of Teladoc Health Inc. fell more than 15% in the extended session Wednesday after the once high-flying telehealth company posted a much larger-than-expected quarterly loss and withdrew its guidance for the year.
Teladoc Stock Falls Below 52-Week Lows On Q2 Earnings: Guidance Withdrawn On BetterHealth Weakness, 'Focused On Addressing The Work Ahead Of Us With Urgency'
Telehealth company Teladoc Health Inc TDOC reported second-quarter financial results after market close Wednesday.
Can Teladoc (TDOC) Q2 Earnings Navigate BetterHelp Profit Woes?
Teladoc's (TDOC) second-quarter results are likely to reflect lower advertising and marketing expenses.
Countdown to Teladoc (TDOC) Q2 Earnings: Wall Street Forecasts for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Teladoc (TDOC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Can the New CEO Revive This Struggling Telehealth Stock?
Virtual healthcare provider Teladoc Health Inc. NYSE: TDOC stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023 earnings, which were further accelerated by its Q1 2024 earnings miss and lowered guidance.
Teladoc (TDOC) Ascends While Market Falls: Some Facts to Note
Teladoc (TDOC) closed the most recent trading day at $9.30, moving +1.2% from the previous trading session.
Shareholders of Teladoc Health, Inc. Should Contact Levi & Korsinsky Before July 16, 2024 to Discuss Your Rights - TDOC
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / If you suffered a loss on your Teladoc Health, Inc. (NYSE:TDOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Teladoc Health, Inc.(TDOC) Shareholders
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / If you suffered a loss on your Teladoc Health, Inc. (NYSE:TDOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Teladoc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 16, 2024 - TDOC
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / If you suffered a loss on your Teladoc Health, Inc. (NYSE:TDOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
